LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 2.66 | 84.90 | 542 | 285 | 1.8968 | 1.8829 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 2.66 | 84.90 | 618 | 285 | 2.1628 | 2.1072 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 4.36 | 84.90 | 626 | 322 | 1.9407 | 1.8219 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 4.36 | 84.90 | 665 | 322 | 2.0616 | 1.9119 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 6.06 | 84.90 | 702 | 365 | 1.9209 | 1.7268 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 6.06 | 84.90 | 738 | 365 | 2.0194 | 1.7923 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.77 | 84.90 | 2 | 411 | 0.0049 | -0.8073 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.77 | 84.90 | 785 | 411 | 1.9089 | 1.6570 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.77 | 84.90 | 837 | 411 | 2.0353 | 1.7329 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 9.47 | 84.90 | 844 | 447 | 1.8863 | 1.6060 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 9.47 | 84.90 | 874 | 447 | 1.9534 | 1.6442 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 11.18 | 84.90 | 929 | 492 | 1.8868 | 1.5690 | MN20160318_Q02 | F19 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 11.18 | 84.90 | 935 | 492 | 1.8990 | 1.5755 | MN20160318_Q02 | G06 |
MCF 10A-H2B-mCherry | Neratinib | 0.018 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | F19 |